Page last updated: 2024-08-24

loxiglumide and Local Neoplasm Recurrence

loxiglumide has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di Prima, F; Militello, C; Pedrazzoli, S; Sperti, C	1

Trials

1 trial(s) available for loxiglumide and Local Neoplasm Recurrence

Article	Year
Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group. Pancreas, 1997, Volume: 14, Issue:3 Topics: Double-Blind Method; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Proglumide; Prospective Studies; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Safety; Survival Analysis	1997

Article

Year

Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group.

Pancreas, 1997, Volume: 14, Issue:3

Topics: Double-Blind Method; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Proglumide; Prospective Studies; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Safety; Survival Analysis

1997